Skye Bioscience, Inc. Common Stock (NASDAQ: SKYE) — Healthcare · Share Price, Chart & Market Data
About: Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.97 (+7.92%)
SKYESkye Bioscience, Inc. Common Stock
Loading watchlist status…
Trade SKYE now
Skye Bioscience, Inc. Common Stock share price
SKYE price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:29 am GMT+0
SKYE price performance
23.819%
5D
55.2%
1M
10.478%
YTD
-45.81%
1Y
SKYE price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:29 am GMT+0
SKYE details
SKYE Market Signals